|

Expressive Writing on Minority Stressors Among Sexual Minority Veterans

RECRUITINGN/ASponsored by VA Office of Research and Development
Actively Recruiting
PhaseN/A
SponsorVA Office of Research and Development
Started2024-03-20
Est. completion2027-10-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

Sexual minority stressors (e.g., sexual minority identity-based discrimination) contribute to greater risk for and severity of depression, anxiety, substance use disorders and suicide among sexual minority Veterans. However, no brief, scalable, one-on-one interventions targeting sexual minority stressor-related distress are available in Veterans Affairs (VA) for sexual minority Veterans. The proposed research will examine the feasibility, acceptability, and preliminary effectiveness of a brief, 3-session expressive writing intervention to target distress related to sexual minority stressor exposure among sexual minority Veterans. The results of this work will advance knowledge about a promising brief and easy to implement intervention focused on reducing depressive and anxiety symptoms among sexual minority Veterans. This proposal aligns with VA's and CSR\&D's commitment to providing equitable services to sexual minority Veterans and the aim of reducing health disparities among underserved Veteran groups.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

Participants will be Veterans who:

* identify as a sexual minority (i.e., identify as gay, lesbian, bisexual, pansexual, queer, or another identity other than heterosexual)
* endorse clinically significant depressive or anxiety symptoms (score above 10 on the PHQ-9 or GAD-7)
* report a history of sexuality-based minority stressor exposure that is contributing to distress on phone screening
* be stable on psychotropic medication for at least 4 weeks if on a psychotropic medication

Exclusion Criteria:

The exclusion criteria for Veterans in this study are:

* clear and current suicidal plan and/or intent (assessed via the Columbia Suicide Severity Rating Scale)
* current presentation of unstable mania and/or psychosis (assessed via the Structured Interview for DSM-5)
* current substance use disorder, severe (assessed via the Structured Interview for DSM-5)
* significant cognitive impairment, including evidence of moderate or severe traumatic brain injury, determined by an inability to comprehend baseline screening questionnaires

Conditions3

AnxietyDepressionDepressive Symptoms

Locations1 site

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130-4817
Kelly L Harper, PhD857-364-4417kelly.harper@va.gov

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.